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ABSTRACT 
 
Retinoic acid (RA) is known to be required at various levels of eye patterning via Retinoic 
Acid Receptors (RAR); however the molecular and cellular mechanisms triggered by these 
nuclear receptors are still obscure. The genetic studies performed here enable us to present a 
new model to study RA action during eye development. By inactivating the three RARs, 
specifically in the periocular mesenchyme, we discriminate the individual contribution of 
each RAR during eye development and describe a new function for RARs during the 
formation of the optic nerve. We demonstrate that RAR! is the only receptor that mediates 
RA signalling in the neurectoderm during ocular development. Surprisingly, and despite a 
sophisticated pattern of RA-activity in the developing retina, we observed that RA signalling 
is not autonomously required in this tissue for eye formation. We show that the action of RA 
during eye morphogenesis is occurring specifically in neural crest-derived periocular 
mesenchyme and is mediated by all three RARs. Furthermore, we point out that Pitx2, which 
encodes a homeodomain transcription factor, is a key RA-responsive gene in neural crest cells 
during eye development. Interestingly, we observed that RA is required in the neural crest 
cells for normal position of the extraocular muscle. 
 
INTRODUCTION 
 
During vertebrate development, the eye is constructed from neural and surface ectoderm as 
well as from the periocular mesenchyme (POM). This latter tissue derives from neural crest 
cells (NCCs) and mesoderm. The primary function of ocular mesenchyme is to provide 
multiple mature cell lineages that are necessary for the development of normal anterior 
segments (including the corneal endothelium, anterior chamber and iris stroma). A second 
essential function is that cells originating from the surface epithelium need to interact with 
POM cells for proper eyelid development (Le Lievre and Le Douarin, 1975). Finally, the 
POM provides essential signals for the specification of retinal pigmented epithelium (RPE) 
and the differentiation of the optic stalk, both structures arising from neural ectoderm (Evans 
and Gage, 2005; Fuhrmann et al., 2000). Failure of proper interactions between these 
ectodermal tissues and the POM results in developmental disorders such as Peters’ anomaly, 
Axenfeld-Riegers’s syndrome or aniridia (Lines et al., 2002). 
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Vitamin A (retinol) is known to be critical for vertebrate eye development as demonstrated by 
severe ocular defects occurring after gestational vitamin A deficiency, such as 
microphthalmia and coloboma of the retina (Dickman et al., 1997). Administration of 
Retinoic acid (RA), the active metabolite of vitamin A, can rescue these eye defects indicating 
that RA mediates the developmental actions of vitamin A (Dickman et al., 1997). RA 
signalling is transduced by specific nuclear retinoic acid receptor heterodimers 
(RXR!/RAR!, RXR!/RAR" and RXR!/RAR#) that act as transcription factors and regulate 
specific target genes during development. During the last decade, extensive work has been 
done to decipher the molecular mechanisms triggered by RA during vertebrate development 
and notably in eye patterning (for a review see (Mark et al., 2006). In particular, numerous 
gene knockout studies have demonstrated that the three RARs (RAR!, RAR" and RAR#) 
play important and overlapping roles during eye development (Ghyselinck et al., 1997; 
Lohnes et al., 1994). Embryos carrying a null mutation of only one RAR display relatively 
minor defects, but loss of function of two RARs results in several ocular abnormalities, 
including malformation of the eyelids, shortening of the ventral retina, coloboma and severe 
malformation of the anterior segment (absence of the iris stroma, the corneal stroma and the 
anterior chamber). 
 
Although obvious redundancy between RARs has been documented, accurate comparison of 
phenotype between various combinations of RAR knockout mice has led to the attribution of 
specific function to a given RAR. For instance, while all three RARs are expressed in 
developing ocular structures (Ghyselinck et al., 1997; Mori et al., 2001), several lines of 
evidence suggest that RXR!/RAR" and RXR!/RAR# are the main heterodimers which are 
instrumental in ocular morphogenesis (Kastner et al., 1997; Zhou et al., 2001). Therefore, a 
clearly established function for RAR! in the eye has not yet emerged. 
 
During development, RA is generated by specific cells in a unique spatio-temporal pattern 
(Rossant et al., 1991). The first enzymatic step, the oxidation of retinol to retinal, is performed 
by the retinol dehydrogenase RDH10 (Sandell et al., 2007). Then, three RA–synthesizing 
enzymes (ALDH1A1, ALDH1A2 and ALDH1A3) are involved in RA synthesis during 
mouse eye development (Matt et al., 2005; Mic et al., 2004). They have distinct tissue-
specific expression patterns from the optic vesicle to the optic cup as ocular formation 
proceeds. The distribution of ALDH1As and the RA-degrading enzymes within the retina 
produces a dorsal and a ventral domain of RA separated by a central zone lacking RA activity 
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(Wagner et al., 2000). This particular dorso-ventral pattern of RA activity observed during 
neural retina formation was initially thought to be crucial for eye development (Wagner et al., 
2000). However, so far no conclusive data has been reported to support such a role for RA 
(Halilagic et al., 2007; Matt et al., 2005; Molotkov et al., 2006). ALDH1A2 which is the first 
enzyme expressed during ocular development is required between E8.5 and E9.5 for the 
initial formation of the optic pit (Mic et al., 2004; Niederreither et al., 1999; Ribes et al., 
2006). Aldh1a3-null embryos display only discrete ocular malformations despite a loss of 
ventral RA signalling (Dupé et al., 2003) and partial loss of dorsal RA signalling in Aldh1a1-
null mice does not induce any abnormal eye development (Fan et al., 2003; Matt et al., 2005). 
Finally, despite a non-overlapping expression pattern of their genes, a functional 
compensation between ALDH1A1, ALDH1A2 and ALDH1A3 has been demonstrated 
(Halilagic et al., 2007; Matt et al., 2005; Molotkov et al., 2006). To date, it has been 
established that during eye morphogenesis, RA is provided by the ALDH1A1 and ALDH1A3 
enzymes expressed in the epithelial compartments of the eye (i.e., the retina, retinal pigment 
epithelium and corneal ectoderm) (Matt et al., 2005; Molotkov et al., 2006). This RA signal 
diffuses in the mesenchymal compartment (i.e., the POM) to activate RXR!/RAR" and 
RXR!/RAR# heterodimers. Thus, RA acts in a paracrine process to pattern the anterior 
segment. It has also been shown that RXR!/RAR" and RXR!/RAR# heterodimers control 
the extent of cell–death involved in POM remodelling and the expression of Foxc1 and Pitx2 
genes (Matt et al., 2005), which are crucial genes for the development of the anterior eye 
segment in mice and humans (Cvekl and Tamm, 2004). Beside this relatively good 
knowledge of RA action during anterior segment development, its function during optic cup 
formation is still largely obscure. 
 
The data obtained with various RA-deficient mouse models demonstrate unambiguously that 
RA is required for several morphogenetic processes during eye organogenesis. By using 
conditional mutations to inactivate all three RARs in the NCCs, we have generated a new 
mouse model where RA activity is entirely absent in the NCC-deriving POM. Not only does 
our work allow us to interpret the disparity of eye phenotypes previously observed in various 
models of RA deficiency, but definitely demonstrates that RA signalling plays key roles in 
eye development exclusively through the POM. 
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METHODS 
 
Mice. Mice, with a mixed C57BL/6–129/Sv (50%:50%) genetic background, were housed in 
an animal facility licensed by the French Ministry of Agriculture (agreement N°B67–218–5) 
and all animal experiments were supervised by NBG who is qualified to experiment with 
mice, in compliance with the European legislation on care and use of laboratory animals 
(agreement N°67–205). Heterozygous mice were mated overnight, and animals with a vaginal 
plug at noon of the next day were considered as embryonic day (E) 0.5. The generation of 
loxP-flanked (floxed) Rara (Rara+/L2), Rarb (Rarb+/L2), Rarg (Rarg+/L2) and Rara-null mice 
have been previously described (Chapellier et al., 2002a; Chapellier et al., 2002b; Chapellier 
et al., 2002c; Lufkin et al., 1993). Wnt1-Cre mouse which carrying a transgene containing a 
Cre cassette under the control of the Wnt1 promoter was obtained from A. McMahon 
(Danielian et al., 1998). The R26R transgenic mice have been previously described (Soriano, 
1999). The Wnt1-Cre and Rara+/L2, Rarb+/L2, Rarg+/L2 parental lines were intercrossed to 
generate mutant foetuses lacking RAR!, RAR" and RAR# in NCCs (hereafter designated 
Rara/b/gNCC-/- mice). The resulting embryos were genotyped for Cre, Rara, Rarb and Rarg 
using PCR-based methods. The embryos of a littermate who does not carry the Wnt1-Cre 
transgene were used as controls. Rara/b/gNCC-/- mice were obtained at a mendelian ratio, but 
newborns died at birth from respiratory distress. 
 
Histology, staining and in situ RNA analysis. For histology experiments, samples were 
fixed in Bouin’s fluid for 5 days, embedded in paraffin, serially sectioned and stained with 
Groat’s hematoxylin and Mallory’s trichrome. For !–galactosidase activity detection, staining 
was performed as described (Rossant et al., 1991). In situ RNA hybridization was carried out 
as described (Dupé et al., 2003). Briefly, the digoxigenin–labeled antisense riboprobes were 
synthesized using cDNA as templates (references upon request). In situ hybridizations were 
performed on serial histological sections along the entire anteroposterior axis of the head. 
Terminal transferase–mediated dUTP-Nick-End-Labeling (TUNEL) was performed using the 
Apoptag® kit (Chemicon International). 
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RESULTS 
 
RAR! is the only mediator of RA signalling in the retina 
 
During early eye development, immunolocalization experiments suggest that Rara, Rarb and 
Rarg genes are all expressed in the cells surrounding the developing optic cup (or POM for 
Peri Ocular Mesenchyme) whereas RAR! would be the only receptor located in the 
developing retina and the retinal pigmented epithelium (RPE) (Mori et al., 2001). 
In order to verify this observation, we examined the RA signalling activity in absence of 
RAR! by crossing a mouse carrying a RAR-lacZ RA-reporter (Rossant et al., 1991) gene with 
the Rara-null mutant. The resulting mouse allowed us to follow the RA signalling activity 
spatiotemporally. We have tested RARE-lacZ activity at E10.5, when RA activity is strong in 
the retina, RPE and corneal ectoderm and present as a weaker signal in the POM (Fig. 1A,C). 
Compared to this characteristic lacZ expression, Rara-null mutant mice carrying the RARE-
lacZ RA-reporter transgene exhibited an alteration of the reporter activity. On external view, 
RA signalling activity in the developing Rara-null eye was slightly reduced in ocular area 
whereas a significant decrease was observed at the level of the forebrain (Fig. 1A and B). To 
further explore lacZ activity in the developing eye, these embryos were sectioned. We 
discovered that RA activity was completely lost specifically at the level of the neural retina, 
the RPE and lens whereas RA activity was normal at the level of the surface ectoderm and the 
POM. Identical lacZ activity was observed at E11.5 and E13.5 (data not shown). These 
observations strongly support that Rara was the only RAR implicated in the transduction of 
RA activity in the neurectoderm of the developing eye. 
 
Retinal morphology in Rara-null mouse is normal 
 
The previous experiment revealed that Rara was the only receptor capable of transducing RA 
signalling in the retina. Consequently, Rara-null mutant gives a unique model to study the 
role of an autonomous-RA signal during retina development. We thus undertook an 
histological analysis of the retina in newborn and adult Rara-null mutants. As shown in Fig. 
1E, newborn mouse retina have a defined ganglion cell layer and the development of other 
layers is still under way. There were no significant morphological differences in the retina of 
control and Rara-null newborn mice, either in terms of retinal thickness or with respect to the 
presence of a ganglion cell layer (Fig. 1E, F). In addition, no morphological differences were 
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observed in the adult retina, as Rara-null retina developed normally, displaying the expected 
lamination (ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform 
layer, outer nuclear layer and photoreceptors segments) with the same degree of thickness as 
that of control mice (Fig. 1G,H). Furthermore, the expression of Tbx5 and Vax2, that are 
respectively dorsal and ventral neural retina markers (McLaughlin et al., 2003), was tested 
and no difference was found between E10.5 Rara-null mutant and control (data not shown). 
Therefore, loss of Rara does not prevent normal lamination of the retina and survival. These 
data suggest that the absence of RA signalling in the retina does not give rise to an obvious 
defect in eye organization. Consequently, RA is not needed autonomously in the neural retina 
and RPE during overall eye morphogenesis. However, to date, no direct functional study and 
quantitative analysis have been performed on Rara-null adult mice. Therefore RAR" could be 
implicated in more subtle developmental processes or in physiological aspects of the vision 
that we do not have analysed in this work. 
 
Rara/b/gNCC-/- triple mutants exhibit more severe ocular defects than Rarb/gNCC-/- double 
mutants 
 
In a previous work, by inactivating Rarg and Rarb specifically in the NCCs of the POM, we 
demonstrated a functional redundancy between RAR" and RAR# during the formation of the 
anterior segment, the eyelids and the ventral retina (Matt et al., 2005). Considering the 
severity of the eye phenotype observed in these mutant mice, we hypothesized at this point 
that the function of RA in POM was mediated by RAR" and RAR#. Nevertheless, in order to 
determine whether RAR! may also function in the POM during ocular development, we 
removed all three RARs from the NCCs (mutant so called Rara/b/gNCC-/-). Mice with the 
alleles of the genes encoding RAR!, RAR" and RAR# floxed (Rara/b/g L2/L2 mice) were 
crossed with the wnt1-Cre transgenic mouse line (Chapellier et al., 2002a; Chapellier et al., 
2002b; Chapellier et al., 2002c; Danielian et al., 1998; Matt et al., 2005). In parallel, all 
combinations of double mutants for RAR in the NCCs were similarly obtained (i.e. Rara/bNCC-
/-, Rarb/gNCC-/- and Rara/gNCC-/-). 
 
Unpredictably, we observed that Rara/b/gNCC-/- mutant displayed a much more severe eye 
phenotype compared to Rarb/gNCC-/- (Matt et al., 2005). Indeed, in contrast to Rarb/gNCC-/-, 
Rara/b/gNCC-/- mutant eyes were not visible externally at E18.5 (Fig. 2A-D). However, 
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examination of histological sections revealed that the two eyes were present in Rara/b/gNCC-/- 
mutants but buried within the skull, near the midline, directly beneath the hypothalamus and 
at the level of the optic chiasma (Fig. 2K). The presence of globes that were not externally 
visible indicated that Rara/b/gNCC-/- mutants were clinically anophthalmic. Interestingly, 
histological examination revealed that the Rara/b/gNCC-/- mutant eyes were attached to the 
ventral hypothalamus rather than connected through an extended optic nerve. Therefore, the 
Rara/b/gNCC-/- mutant eye was characterized by the presence of the lens and retina deep within 
the head mesenchyme with no evidence of optic nerve differentiation (Fig. 2H-K). 
Notably, Rara/b/gNCC-/- embryos had normal lens vesicles at E14.5 suggesting that lens 
induction and invagination had proceeded normally in all mutants. However, their lens was 
rotated ventrally and distant from the surface. At E18.5, the lens was generally hypoplasic, 
probably due to its deep location during organogenesis and the presence of a persistent 
retrolenticular membrane that completely filled the space between the retina and the lens (Fig. 
2H-K). In E14.5 Rara/b/gNCC-/- embryos, the dorsal retina was well developed, and both neural 
and pigment epithelium layers were present. At the opposite, the ventral retina was absent or 
poorly developed, resulting in a complete coloboma (Fig. 2H,I). Moreover, Rara/b/gNCC-/- 
mutant eyes display eversion of the remaining ventral retina that arises from the 
transformation of RPE into neural epithelium. As a consequence, ventral RPE was never 
observed in the ventral side (Fig. 2K). The dorsal retina and the remnant ventral retina of the 
Rara/b/gNCC-/- mutant appeared to be normally multilayered and, despite the absence of optic 
nerve, the extend axons entered the ventral hypothalamus and formed the optic chiasma (Fig. 
2H-K). Both the optic nerve and ventral retina arise from neural ectoderm, indicating that one 
essential function of RA in the periocular NCCs is to influence the development of the neural 
ectoderm. 
 
Multiple structures partially or totally arising from neural crest are also absent in Rara/b/gNCC-
/- eyes. Similarly to Rarb/gNCC-/- mutants (Matt et al., 2005) (Fig. 2F and Table 1), the corneal 
endothelium and stroma, anterior chamber and eyelids which receive contributions from 
neural crest and mesoderm, were absent in Rara/b/gNCC-/- mutant eyes and were replaced by a 
thick layer of loosely organized mesenchyme (Fig. 2H,I). The sclera surrounding the eye 
deriving from the neural crest was completely absent (Fig. 2K). Interestingly, Rara/gNCC-/- 
mutants (Fig. 2G and Table 1) and Rara/g-double null mutants both display a similar 
phenotype: the eye was buried, the optic nerve was present but shorter and the ventral retina 
was underdeveloped (Lohnes et al., 1994). Importantly, in Rara/gNCC-/- mutants and Rara/g-
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double null mutants the anterior segment and eyelids were malformed but not completely 
absent compared to Rara/b/gNCC-/- and Rarb/gNCC-/- mutants. To resume, whereas the Rara/bNCC-
/- eye phenotype was mild, consisting only in a persistent retrolenticular membrane, both 
Rara/gNCC-/- and Rarb/gNCC-/- mutants presented a severe eye phenotype (Table 1). Nonetheless, 
these phenotypes are milder compared to the Rara/b/gNCC-/- eyes. Interestingly, the elongation 
of the optic nerve is affected in Rara/gNCC-/- mutants but not in Rarb/gNCC-/- embryos whereas 
the anterior segment was more affected in Rarb/gNCC-/- embryos compared to Rara/gNCC-/-. 
Altogether, these data suggest that the 3 RARs were implicated in the POM with specific 
function for each receptor. 
 
Morphological defects in Rara/b/gNCC-/- eye primordia begin at E10.5 
 
To identify the origin of the accumulated eye defects, we examined Rara/b/gNCC-/- embryos 
after NCCs migration (i.e. E9.5). We used the mouse line bearing a conditional reporter 
transgene (R26Rtg/0), which expresses !-galactosidase only upon Cre-mediated recombination 
of a loxP-flanked (floxed) intervening DNA sequence (Soriano, 1999). This line was crossed 
with the Rara/b/gNCC-/- mice and resulting embryos (designated Rara/b/gNCC-/-lacZ) were taken at 
E9.5. First, we observed the pattern of !-galactosidase activity identifying NCC derivatives 
and concluded that they were identical in eye area of E9.5 Rara/b/gNCC-/-lacZ and WTlacZ 
embryos (Fig. 3A, B). Thus, we demonstrate that ablation of all 3 RARs in NCCs does not 
alter their migration into the periocular region. These data allowed us to verify that the 
morphological defects observed in Rara/b/gNCC-/- mutants did not result from alteration of 
NCCs migration. Importantly, we observed that mutant and control optic vesicles were 
histologically indistinguishable until E10.5 (Fig. 3A-D). Then, from this stage, Rara/b/gNCC-/- 
eye phenotype is characterized by a systematic absence of the ventral eyelid groove. In 
contrast, the optic stalk and optic cup were similar in both control and mutant (arrowhead in 
Fig. 3E,F). 
 
By E11.5, the eye defects of the Rara/b/gNCC-/- mutant became very drastic and were 
recognizable externally (data not shown) as pigmented cells were not observed on the ventral 
side of the eye (Fig. 3G,H). The initial specification of the RPE appeared to occur normally in 
Rara/b/gNCC-/- embryo, since the mutant dorsal RPE was indistinguishable from the control at 
E10.5 (Fig. 3E, F). However, at E11.5, when the RPE becomes pigmented, no pigment-
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containing cells were observed in the remnant ventral RPE of the Rara/b/gNCC-/- mutant (data 
not shown), suggesting that the expansion of the ventral RPE was blocked in the mutant eyes. 
As a consequence, an eversion of the ventral retina is observed at E14.5 and E18.5 (Fig. 2H, 
K). In addition, the optic stalk in Rara/b/gNCC-/- mouse remained a thick neuroblastic structure 
whereas in control embryos, the optic stalk had begun to extend and thin down, leading to the 
normal distance between the optic cup and the ventral diencephalon (Fig. 3G, H). As a result, 
the mutant eye remains closely associated with the ventral diencephalon by E14.5 (Fig. 2H). 
 
It has been shown previously that RA triggers apoptosis in the POM during eye formation. 
Indeed, the 2 physiological apoptotic clusters observed in the POM during eye development 
are not found in Rarb/gNCC-/- E11.5 mutants (Matt et al., 2005). To investigate the RA-
dependent physiological function of programmed cell death during Rara/b/gNCC-/- eye 
formation, a TUNEL assay was performed on serial histological sections along the 
anteroposterior axis of the eye region at E10.0 and E11.5 (Fig. 3C,D and G,H). As expected, 
the normal apoptotic clusters were consistently not detected in the POM of Rara/b/gNCC-/- 
E11.5 embryos (Fig. 3G, H and data not shown). Interestingly, as illustrated in Figures 3 (G 
and H) and previously shown by others (Cuadros and Rios, 1988; Ulshafer and Clavert, 
1979), optic nerve formation is also associated with a marked apoptotic cell death. However, 
this wave of dying cells in the forming optic nerve was similarly observed in the E10.0 and 
E11.5 mutant and control embryos (Fig. 3C,D and G,H). Therefore, our data show that the 
abnormal development of optic nerve observed in Rara/b/gNCC-/- mutant mice is not correlated 
with an abnormal regulation of apoptosis. Although the undifferentiated mesenchyme in the 
POM area of the E14.5 Rara/b/gNCC-/- mutants suggested that the anterior segment was 
hypercellular, we were unable to find evidence of increased proliferation in the POM of 
Rara/b/gNCC-/- mutant mice at E10.5 and E11.5 (data not shown). 
 
Pitx2 is not expressed in periocular mesenchyme of Rara/b/gNCC-/- mutants 
 
Amongst the genes involved in ocular development, the homeodomain transcription factor 
PITX2 has been designated as a key protein, playing essential functions during anterior 
segment patterning (Evans and Gage, 2005). At E11.5 this gene is expressed in the POM, 
especially in the presumptive anterior segment. Interestingly, we have previously reported 
that in E11.5, Rarb/gNCC-/- embryos, Pitx2 expression is reduced in the POM dorsal region 
(Matt et al., 2005). Subsequent to this work, a mutant mouse in which Pitx2 expression is 
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specifically inactivated in NCCs (Pitx2NCC-/-) has been described (Evans and Gage, 2005). This 
mutant is characterized by an abnormal anterior segment differentiation, an absence of eyelids 
and exhibited a failure to maintain the optic nerve. Interestingly, the same defects are 
observed in Rara/b/gNCC-/- mutant. We therefore tested the expression of Pitx2 in Rara/b/gNCC-/- 
mutant. Importantly, we observed that Pitx2 expression was totally absent in the periocular 
area of the Rara/b/gNCC-/- E11.5 embryos (n=3, Fig. 4A, B) whereas its expression in the 
pharyngeal ectoderm was not altered, demonstrating that the expression of Pitx2 in the POM 
required RA signalling. Therefore, the specific absence of Pitx2 expression in Rara/b/gNCC-/- 
demonstrates that Pitx2 is a target of RA signalling in the POM. 
 
Among the other genes involved in ocular development and potential target of RA, Gas1 
(Growth arrest specific gene 1) is a relevant candidate. Indeed, Gas1-null mouse present 
microphthalmia, anterior segment defects and eversion of the ventral retina (Lee et al., 2001). 
Furthermore, microarray experiments using F9 embryonic carcinoma cells exposed to RA 
suggest that Gas1 would be a RA-responsive gene (Eifert et al., 2006). As shown on figure 
4C, Gas1 expression is detected at E11.5 in the dorsal and ventral tip of the retina and in the 
mesenchyme surrounding the eye (i.e POM). However, this expression of Gas1 in the POM is 
similar in control mouse as in Rara/b/gNCC-/- mutant (Fig. 4C, D). These data indicate that Gas1 
is not a target of RA signalling in the POM, and also that the absence of RA signalling in the 
NCCs does not globally disrupt gene expression in POM cells, but selectively decreases 
Pitx2. 
 
Initial patterning of retina and optic nerve is not affected in Rara/b/gNCC-/- mutants 
 
To this date, only a few mutant mouse strains display a failure of morphogenetic extension of 
the optic nerve. This severe defect in optic nerve development was described in Pitx2NCC-/- 
(Evans and Gage, 2005). Importantly, it has been shown that the absence of the optic nerve in 
this mutant was not due to a lack of initial specification, since the expression of an early 
marker of the optic stalk like Pax2 is normal (Torres et al., 1996). On the basis of a similar 
severe optic nerve phenotype in the Rara/b/gNCC-/- mutant and a down-regulation of Pitx2 in 
this mutant, we have tested Pax2 expression at E11.0. Similarly to Pitx2NCC-/- mutant, we 
observed that Pax2 was normally expressed in the optic stalk of both control and Rara/b/gNCC-
/- mutant (Fig. 4G,H), establishing that a lack of initial specification cannot account for the 
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optic stalk defects. In addition, and considering the absence of ventral retina in E11.5 
Rara/b/gNCC-/- mutant, we have evaluated the dorsoventral polarity of the Rara/b/gNCC-/- mutant 
retina by studying the expression of Tbx5 and Vax2 (McLaughlin et al., 2003). We did not 
find any difference in the expression patterns of Vax2 and Tbx5 between Rara/b/gNCC-/- mutant 
and control eye at E10.5 (Fig. 4I, J and data not shown). Since the polarity of the neural retina 
is presumed to be determined at E9.5, it indicates that initial patterning of the retina was not 
significantly affected. 
 
Extraocular muscles are ectopic in Rara/b/gNCC-/- mutants 
 
The extraocular muscles, which contain mainly mesoderm-derived myocytes but also neural 
crest-derived fascia cells, are normally present as mesenchymal condensations lateral to the 
optic cup and are characterized by the expression of Pitx2 at E11.5 (Fig. 4A). During our 
histological analysis of Rara/b/gNCC-/- mutant, we observed that extraocular muscle was not 
present in the periocular area (Fig. 2E, H-K). We thus extended our analysis to the whole 
head using serial sections. From this work, we detected a muscle-like tissue between the 
trigeminal ganglion and the pituitary (Fig. 4F). In addition, this muscle-like tissue exhibited 
specific mesodermal expression of Pitx2 (Fig. 4F) (Kitamura et al., 1999). These ectopic 
muscle-like structures were still present at E14.5 between the trigeminal ganglion and the 
pituitary (data not shown). Altogether, these observations demonstrated that muscles were 
properly formed in mutant mice but localized more caudally compared to its normal position 
lateral to the optic cup. This result strengthens a recent report suggesting that early 
craniofacial myogenesis is NCC-independent whereas migration of head muscle cells would 
be regulated by cranial NCCs (Rinon et al., 2007). Interestingly, this new model of total RA-
deficiency in NCCs has highlighted an unexpected role for RA signalling in ocular muscle 
positioning. We therefore propose that RA in the NCCs provide guidance cues to allow 
muscle precursor cells to migrate to the correct position in the embryonic head. 
 
 
DISCUSSION 
 
Sophisticated experimental genetics in mice provides a powerful approach to understand 
developmental process by allowing precise molecular, cellular and temporal dissection of 
gene function. Tissue-specific knockouts are particularly useful when trying to understand the 
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function of a gene that is expressed in multiple cell lineages of a developing organ. The triple 
Rara/b/gNCC-/- mutants generated here give a new model to study RA function during eye 
development and the data presented in this manuscript provide essential new information 
toward the understanding of mammalian eye patterning. In particular, our data demonstrate 
definitely the essential role of RA in the POM to pattern the optic vesicle. 
 
Eye development results from complex cell interactions between neurectoderm (which give 
rise to the retina and optic nerve), the surface ectoderm (which give rise to the lens, epithelia 
of the cornea, conjunctiva and eyelids) and NCC-derived mesenchyme (which forms the 
choroids, sclera, stroma of the cornea and iris, anterior chamber and vitreous body) (Le 
Douarin et al., 1993). Previous studies using either vitamin A deficiency models, Rdh10, 
Aldh1a or Rar mutants have demonstrated that RA signalling is crucial for the formation of 
all these ocular structures (Dickman et al., 1997; Halilagic et al., 2007; Lohnes et al., 1994; 
Mark et al., 2006; Matt et al., 2005; Sandell et al., 2007). Consequently, it was thought that 
RA was required for various morphogenetic processes in various eye tissues and at several 
stages to pattern eye formation. 
In contrast to this general assessment, we show that the complete removal of RA activity only 
in the NCCs recapitulates all eye malformations previously described in the various RA-
deficient models (Halilagic et al., 2007; Lohnes et al., 1994; Mark et al., 2006). We have 
thereby demonstrate for the first time that the only target of RA signalling is the NCC-derived 
mesenchyme and that impairing this signal in this tissue is sufficient to alter the entire eye 
morphogenesis. 
 
RA is not required in the retina during its lamination 
 
In the present study, we show that RA activity was absent from the developing retina and 
RPE in a Rara-null mutant between E10.5 and E13.5. By this experiment, we demonstrated 
that Rara is the only RAR capable to efficiently mediate RA activity in the developing retina 
and RPE.  
Previously it was hypothesized that RA maybe involved autonomously in dorsoventral 
patterning of the retina based upon the dorsal and the ventral expression patterns of Aldh1a1 
and Aldh1a3 respectively in the retina from E10.5. However, studies on Aldh1a1-/-Aldh1a3-/- 
embryos have shown that a lack of RA signalling in the retina from E10.5 does not affect 
expression of dorso-ventral key determinants like Tbx5 and Vax2 (Matt et al., 2005; Molotkov 
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et al., 2006). Additionally, the absence of RA-signalling in Rara-null retina did not alter the 
expression of Vax2 and Tbx5. This indicates that RA does not have an autonomous function in 
the dorso-ventral patterning of the retina. Furthermore, the fact that Tbx5 and Vax2 are 
normally expressed in the Rara/b/gNCC-/- retina indicates that initial dorsoventral patterning is 
also not affected and that RA does not regulate these genes by a cell non-autonomous process. 
 
Moreover, a later autonomous function for RA in the retina or RPE should have been revealed 
by the Rara-null mutant. However, no detectable eye defects were observed in adult Rara-
null mutant eye. Thus, our genetic studies demonstrate conclusively that RA signalling has no 
autonomous function during retinal lamination. Thus RA is dispensable within the retina for 
the formation of the eye. However, an autonomous role for RA in more elaborate 
specialization of the retina is still conceivable as our histological study cannot rule out 
eventual more subtle defects in adult retina.  
 
 
RAR!, RAR" and RAR# are differently required in the periocular mesenchymal 
NCCs 
 
Since RAR" and RAR# are essential in the POM (Matt et al., 2005), it had been postulated 
that these 2 receptors were the main receptors involved in RA signalling in this tissue. In this 
study, we found major ocular defects in Rara/gNCC-/- and Rarb/gNCC-/- but not in Rara/bNCC-/-. 
Simultaneously, using the same approach, we also demonstrated that RAR# was crucial for 
normal differentiation of the craniofacial NCCs (V.D, unpublished). Altogether, it suggests 
that RAR# is the most important RAR implicated in cranial NCCs differentiation. Besides 
highlighting the role of RAR# in NCCs differentiation, our data gives a better understanding 
of the role of RAR! during eye development. Although comparison between phenotypes of 
RAR double null mutants has suggested a role for RAR! in eye development (Lohnes et al., 
1994), no studies were available to attribute a specific function to this receptor. Here, we 
observed a strong genetic interaction in the POM between Rara, Rarb and Rarg, 
demonstrating clearly a function of RAR! in this tissue. Precisely, complete absence of the 
optic nerve has never been observed in the various combinations of Rar-double null mutants. 
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Furthermore, our data demonstrate that the role of each RAR is not equivalent during ocular 
morphogenesis and that they are specialized in patterning different NCCs-dependent 
structures. Rarb/gNCC-/- mutants have the anterior segment and eyelids preferentially affected 
whereas the optic nerve is normal and the ventral retina is present while slightly shorter. In 
contrast, the couple of RAR! and RAR# is more important for optic disc invagination and 
nerve optic differentiation since their inactivation in the POM produces an hypoplasic optic 
nerve whereas the anterior segment and eyelid formation is less severely affected compared to 
those of Rarb/gNCC-/- mutants. Thus, RAR" is specifically involved cell-autonomously within 
the anterior segment whereas RAR! is rather implicated cell-non autonomously during optic 
disc invagination and optic nerve maintenance. 
 
During eye formation, RA signalling emerges in specific regions while the eye undergoes a 
dramatic remodelling. In this sophisticated process, the specific function of each ALDH1A 
and RAR were not clear until now. Here, we clarify the sequential contribution of each actor 
of the RA signalling to eye morphogenesis. By inactivating all 3 RARs in the POM, we 
largely recapitulated the spectrum of eye phenotype of Aldh1a2-/-Aldh1a3-/- mutant that have 
been RA supplemented between E7.5 and E8.5 to rescue heart failure (Halilagic et al., 2007). 
This Aldh1a2-/-Aldh1a3-/- mutant supplemented before E8.5 shows no more RA-signal in the 
ocular region at E9.5 (Halilagic et al., 2007; Molotkov et al., 2006) suggesting that 
ALDH1A2 and ALDH1A3 are the main RA-producing enzyme in the POM at this stage. 
These data, as well as the results described herein, demonstrate that the absence of RA 
signalling in the ocular region from E9.5 is implicated in the apparition of the Rara/b/gNCC-/- 
eye phenotypes. Thus, at this stage, RA produced by ALDH1A2 and ALDH1A3 in the POM 
stimulates the invagination of the optic vesicle and the formation of the optic nerve (Molotkov 
et al., 2006). Here, we have shown that this event is mainly mediated by RAR! and RAR# in 
the POM and is therefore cell-non autonomous. Subsequently, no additional RA-signal is 
found in the ocular region of the Aldh1a1-/-Aldh1a3-/- mutant from E10.5 (Matt et al., 2005; 
Molotkov et al., 2006). Thus, RA production is exclusively performed by ALDH1A1 and 
ALDH1A3 from this stage. As the phenotype of Aldh1a1-/-Aldh1a3-/- mutant is similar to 
Rarb/gNCC-/- phenotype (Matt et al., 2005), this RA mainly activates RAR" and RAR# to 
pattern the anterior segment, eyelids and late invagination of the retina. A schematic 
presentation of these overall data is given in figure 5. 
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RA in the POM is crucial for optic nerve maintenance 
 
The ocular defects observed in Rara/b/gNCC-/- mutants such as abnormalities of the cornea, 
eyelids, anterior chamber, and presence of PHPV, all correlate with the abnormal 
differentiation of cranial NCCs (Cvekl and Tamm, 2004). This part of the phenotype has been 
described in Rarb/gNCC-/- mutants and was found to be associated to a decrease of Pitx2, Foxc1 
and Eya2 expression in POM cells (Matt et al., 2005). Here, by additionally removing RAR! 
in the NCCs, we have found that Pitx2 expression is fully abolished in the POM. 
Interestingly, recent data have demonstrated that specific inactivation of Pitx2 in the NCCs 
induces an anterior segment dysgenesis but also defects in the maintenance of the optic nerve, 
which closely resemble the ocular defects displayed by Rara/b/gNCC-/- mutant mice (Evans and 
Gage, 2005). 
As RA and PITX2 are both required in the periocular NCCs and as PITX2 is absent in the 
POM of Rara/b/gNCC-/- mutant mouse, RA and Pitx2 are involved in a simple linear genetic 
pathway. In this genetic cascade, we propose that RARs are upstream of this pathway and 
control the expression of Pitx2, which in turn is required for anterior segment differentiation 
and optic nerve maintenance. While the involvement of Pitx2 in RA signalling is clear from 
our experiments, a direct action of RA on Pitx2 promoter remains unclear. We therefore 
performed an in silico analysis of the Pitx2 gene and found no RARE sequence in its 
promoter. In addition, the analysis of microarray experiments did not identify Pitx2 as a direct 
RA inducible gene. Therefore RA would regulate Pitx2 indirectly through a transcription 
intermediary (Balmer and Blomhoff, 2002; Eifert et al., 2006). 
In various models of RA-deficiency, including the Rara/b/gNCC-/- mutant, anterior segment 
defect was associated with reduced apoptosis (present data; (Matt et al., 2005). Since, the 
same anterior segment defects are observed in Rara/b/gNCC-/- and Pitx2NCC-/- mutants, it can be 
suggested that Pitx2 triggers cell apoptosis in a linear genetic pathway regulated by RA. 
However, since cell death was not studied in the Pitx2NCC-/- mutant, we cannot conclude firmly 
that this linear genetic pathway leads to cell apoptosis. In this process, Eya2 (Clark et al., 
2002) could also be involved since its decreased expression in the POM was described for 
Rarb/gNCC-/- mutants (Matt et al., 2005). 
 
Other genes could also be included in this cascade. The transcription factors Lmx1b and 
Foxc1 are notably required for normal anterior segment development. These genes are co-
expressed within the POM and their inactivation results in anterior segment defects, although 
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less severe compared to those of Pitx2NCC-/- and Rara/b/gNCC-/- mutants (Kidson et al., 1999; 
Pressman et al., 2000). Furthermore, the regulation of Foxc1 by RA (Matt et al., 2005) 
strengthens the hypothesis that these genes are involved in the RA-dependent molecular 
mechanism leading to anterior segment morphogenesis. 
 
The striking new phenotype of the Rara/b/gNCC-/-, as compared to the other RARs loss-of-
function models, is the absence of optic nerves. These new data demonstrate that the POM is 
instrumental for optic nerve maintenance in a RA-dependent process. Most interestingly, 
Rara/b/gNCC-/- as Pitx2NCC-/- mutants displayed the same absence of optic nerve (present data 
and (Evans and Gage, 2005). Indeed, both mutants exhibit normal initial specification of the 
optic stalk as testified by the expression of Pax2, followed by a failure to maintain the optic 
nerve. Since these conditional mutants (Rara/b/gNCC-/- and Pitx2NCC-/-) are specifically 
inactivated in the NCCs, the defect of the optic stalk observed is the result of an impairment 
of an extrinsic signal arising from the POM. We thus propose that RA in the POM controls 
Pitx2 expression which, in turn, activates a yet unknown paracrine factor that subsequently 
conditions the morphogenetic extension of the optic stalk. We also point out that a cell-
autonomous (formation of the anterior segment) and non-autonomous (optic cup 
morphogenesis) mechanisms, both RA-dependent, involve the same target gene, i.e. Pitx2.  
 
Altogether, our work clearly demonstrates that RA is not cell-autonomously required in the 
neurectoderm to pattern eye morphogenesis. In contrast, ocular development required RA 
producing ectodermal cells, sending this RA signal to the POM, which in turn acts on retina. 
It thus questions the presence of sophisticated Aldh1as expression in the retina during eye 
development as previously described (Wagner et al., 2000). It could be speculated that such 
timely and regionally regulated RALDH expression could be an evolutionary relic of an 
important mechanism present in lower vertebrates. Another hypothesis is that such ALDH1As 
expression is indispensable for retinal differentiation in order to acquire an elaborate retina 
with high-acuity.  
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FIGURES LEGENDS 
 
Table 1: Eye abnormalities present in Rara/bNCC-/-, Rarb/gNCC-/-, Rara/gNCC-/- and Rara/b/gNCC-/-. 
Note that the single abnormality observed in Rara/bNCC-/- mutant, consisting of a persistent 
retrolenticular membrane, was also observed in RarbNCC-/- single mutant. 
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Figure 1: Effects of Rara inactivation on the RA-dependent activity of a RARE-lacZ reporter 
transgene. Distribution of !#galactosidase activity driven by the RARE-lacZ transgene in WT 
(A,C) and Rara-null mutants (B,D) at E10.5 (A-D). RARE-lacZ activity is abolished in Rara-
null in the retina, RPE and lens but not in the surface ectoderm and mesenchymal cells. C and 
D are sections from A and B respectively. Note the reduced RA activity at the level of the 
forebrain. Aspects of retinal histogenesis in WT and Rara-null mutant at birth (E,F) and 
adulthood (G,H). c, presumptive corneal ectoderm; ch, choroids; e, eye; f, forebrain; gcl, 
ganglion cell layer; inl, inner nuclear layer; ipl, inner plexiform layer; le, lens; mx, maxillary 
part of first branchial arch; n, optic nerve; onl, outer nuclear cell layer; opl, outer plexiform 
layer; pom, periocular mesenchyme; ps, photoreceptor segments; r, neural retina; rpe, retinal 
pigmented epithelium. 
 
Figure 2: Partial or complete absence of RA signalling in the POM results in severe ocular 
defects. (A-D) External view of E18.5 foetus eye areas. (E-K) Frontal histological sections 
through heads of E14.5 (E-I) and E18.5 (J,K) foetuses. In order to illustrate the shortening of 
the optic nerve, the orientation of the eye in G is more transversal, this section does not allow 
illustration of the shortening of the ventral retina. Asterisks (F-I, K) indicate undifferentiated 
mesenchyme replacing the eyelids and cornea. Arrowhead (A, B and C) indicates the eye. c, 
cornea; d, dorsal retina; e, ear; el, eyelid; er, eversion of the retina; le, lens; m, extraocular 
muscle; n, optic nerve; oc, optic chiasma; p, persistent retrolenticular membrane; rpe, retinal 
pigment epithelium; v, ventral retina. 
 
Figure 3: Defects in Rara/b/gNCC-/- eye primordial begin at E10.5. Frontal histological sections 
through head of E9.5 (A,B), E10.0 (C,D), E10.5 (E,F), E11.5 (G,H) genotypes as indicated. 
(A, B) distribution of !-galactosidase activity driven by the R26R transgene in (A) WT and 
(B) Rara/b/gNCC-/- E9.5 embryos that are histologically similar. The !-galactosidase staining is 
identical, indicating that ablation of all three RARs does not alter the migration of NCCs in 
the POM. (C,D and G,H), Distribution of apoptotic cells (assessed by TUNEL assays). Note 
the absence of the ventral eyelid groove (arrowhead in F).  Square brackets (C and D) indicate 
physiological apoptosis in optic stalk. Asterisks (H) indicate undifferentiated mesenchyme 
replacing the eyelids and cornea. a, apoptotic cluster in the POM. b, brain; d, dorsal retina; le, 
lens; m, muscle; n, optic nerve; n*, undifferentiated optic nerve; os, optic stalk; ov, optic 
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vesicle; pom, periocular mesenchyme; r, neural retina; rpe, retinal pigmented epithelium; v, 
ventral retina. 
 
Figure 4: Ablation of Rara, Rarb and Rarg in neural crest cells impairs gene expression in the 
POM but not in the retina. (A-J). In situ hybridization with digoxigenin-labeled Pitx2, Gas1, 
Vax2 and Pax2 on frontal sections. Note the persistent expression of Pitx2 in the pharyngeal 
ectoderm of the Rara/b/gNCC-/- mutants. b, brain; d, dorsal retina; g5, trigeminal ganglion; le, 
lens; m, muscle; n, optic nerve; n*, undifferentiated optic nerve; o, oral cavity; p, pituitary; 
pe, pharyngeal ectoderm; pom, periocular mesenchyme; rpe, retinal pigmented epithelium; v, 
ventral retina. 
 
 
Figure 5: ALDH1A1, ALDH1A2, ALDH1A3, RAR!, RAR" and RAR# participate 
sequentially to eye morphogenesis. At E9.5, RAR! and RAR# are activated by RA produces 
by ALDH1A2 and ALDH1A3 to determine non-autonomously the RA-dependent optic nerve 
morphogenesis and invagination of the retina. Subsequently, from E10.5, RAR" and RAR# 
are activated by RA produces by ALDH1A1 and ALDH1A3 to determine non-autonomously 
the late retinal invagination process and to control autonomously anterior segment 
morphogenesis. Light blue indicates that the contribution of this specific RAR to the 
formation of the corresponding eye structure is weaker. Thick arrow represents the 
progressive RA-dependent stage of the various eye structures. 
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Eye defects   
 
E14.5 
E18.5 
Rara/bNCC-/- 
 
n = 4 
n = 2 
Rarb/gNCC-/- 
 
n = 4 
n = 2 
Rara/gNCC-/- 
 
n = 3 
n = 3 
Rara/b/gNCC-/- 
 
n = 6 
n = 4 
Shorter ventral retina 0% 100% 100% 100% 
Complete agenesis of the ventral retina 0% 0% 0% 80% 
Lens rotation 0% 100% 100% 100% 
Persistent retrolenticular membrane 100% 100% 100% 100% 
Absence of the optic nerve 0% 0% 0% 100% 
Corneal lenticular stalk 0% 100% 100% 100% 
Anterior segment defects 0% 100% 100% (partial) 100% 
Eversion of the retina 0% 0% 100% 100% 
Coloboma 0% 0% 100% 100% 
Agenesis of the eyelid 0% 100% 100% (partial) 100% 
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